Clarissa L. Velayo

Prof. Clarissa L. Velayo

University of the Philippines Manila, Manila, Philippines
+1
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2021 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
Ourlad Alzeus G. TantengcoOurlad Alzeus G. Tantengco
Ourlad Alzeus G. Tantengco
MSMariana de Castro Silva
Mariana de Castro Silva
CVClarissa L. Velayo
Clarissa L. Velayo

26 June 2017 in Frontiers in Physiology
Verified
Journal Article
Open access
CVClarissa L. Velayo
Clarissa L. Velayo
KFKiyoe Funamoto
Kiyoe Funamoto
JSJoyceline Noemi I. Silao
Joyceline Noemi I. Silao
YKYoshitaka Kimura
Yoshitaka Kimura
KNKypros Herodotos Nicolaides
Kypros Herodotos Nicolaides
OBJECTIVES. This descriptive study was performed to evaluate the capability of a non-invasive transabdominal electrocardiographic system to extract clear fetal electrocardiographic (FECG) measurements from intrauterine growth restricted (IUGR) fetuses and to assess whether abdominal FECG parameters can be developed as markers for evaluating the fetal cardiac status in IUGR. METHODS. Transabdominal FECG was attempted in 20 controls and 15 IUGR singleton pregnancies at 20+0-33+6 weeks gestation. Standard ECG parameters were compared between the study groups and evaluated for their correlation. Accuracy for the prediction of IUGR in cut off values of the different fetal electrocardiographic parameters was also determined. RESULTS. Clear P-QRST complexes were recognized in all cases. In the IUGR fetuses, the QT and QTc intervals were significantly prolonged (p = 0.017 and p = 0.002, respectively). There was no correlation between ECG parameters and Doppler or other indices to predict IUGR. The generation of cut off values for detecting IUGR showed increasing sensitivities but decreasing specificities with the prolongation of ECG parameters. CONCLUSION. The study of electrocardiophysiology is now feasible through a non-invasive transabdominal route. This study confirms the potential of FECG as a potential clinical screening tool to aid diagnosis and management of fetuses after key limitations are addressed. In the case of IUGR, both QT and QTc intervals were significantly prolonged and thus validate earlier study findings where both these parameters are found to be markers of diastolic dysfunction. This research is a useful prelude to a test of accuracy and Receiver Operating Characteristics (ROC) study.

27 January 2011 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
PDF file
CVClarissa L. Velayo
Clarissa L. Velayo
NSNaoaki Sato
Naoaki Sato
TITakuya Ito
Takuya Ito
HCHiroshi Chisaka
Hiroshi Chisaka
NYNobuo Yaegashi
Nobuo Yaegashi
YKYoshitaka Kimura
Yoshitaka Kimura

20 December 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
CVClarissa L. Velayo
Clarissa L. Velayo
KRKareen N. Reforma
Kareen N. Reforma
RSRenee Vina G. Sicam
Renee Vina G. Sicam
MDMichele H. Diwa
Michele H. Diwa
ASAlvin Duke R. Sy
Alvin Duke R. Sy
Ourlad Alzeus G. TantengcoOurlad Alzeus G. Tantengco
Ourlad Alzeus G. Tantengco
This study compared the diagnostic performance of different ultrasound-based models in discriminating between benign and malignant ovarian masses in a Filipino population. This was a prospective cohort study in women with findings of an ovarian mass on ultrasound. All included patients underwent a physical examination before level III specialist ultrasonographic and Doppler evaluation using the different International Ovarian Tumor Analysis (IOTA) Group’s risk models. Serum CA-125 and a second-generation multivariate index assay (MIA2G) were also determined for all patients. The ovarian imaging and biomarker results were correlated with the histological findings. A total of 260 patients with completed ultrasound, CA-125, MIA2G, and histopathologic results was included in the study. The presence of papillae with blood flow and irregular cyst walls during the ultrasound were significantly associated with a 20-fold (OR: 20.13, CI: 8.69–46.67, p < 0.01) and 10-fold (OR: 10.11, CI: 5.30–19.28, p < 0.01) increase in the likelihood of a malignant lesion, respectively. All individual sonologic procedures performed well in discerning malignant and benign ovarian lesions. IOTA-LR1 showed the highest accuracy (82.6%, 95% CI: 77.5–87%) for identifying ovarian cancer. IOTA-ADNEX showed the highest sensitivity (93.3%, 95% CI: 87.2–97.1%) while IOTA-LR2 exhibited the highest specificity (84.4%, 95% CI: 77.3–90%). Among the different serial test combinations, IOTA-LR1 with MIA2G and IOTA-LR2 with MIA2G showed the highest diagnostic accuracy (AUROC = 0.82). This study showed that all individual ultrasound-based models performed well in discerning malignant and benign ovarian lesions, with IOTA-LR1 exhibiting the highest accuracy.

23 February 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
SPSheriah Laine M. de Paz-Silava
Sheriah Laine M. de Paz-Silava
ITIan Kim B. Tabios
Ian Kim B. Tabios
Ourlad Alzeus G. TantengcoOurlad Alzeus G. Tantengco
Ourlad Alzeus G. Tantengco
Fresthel Monica M. ClimacosaFresthel Monica M. Climacosa
Fresthel Monica M. Climacosa
CVClarissa L. Velayo
Clarissa L. Velayo
LDLeslie Michele M. Dalmacio
Leslie Michele M. Dalmacio
HPV infection is one of the most studied risk factors in cervical cancer—the second most common cancer site and cause of death due to cancer in the Philippines. However, there is a lack of population-based epidemiological data on cervical HPV infection in the Philippines. Local reports on co-infections with other lower genital tract pathogens, commonly reported globally, are also lacking, which emphasizes the need to increase efforts in targeting HPV prevalence, genotype, and distribution. Hence, we aim to determine the molecular epidemiology and natural history of HPV infection among reproductive-age Filipino women using a community-based prospective cohort design. Women from rural and urban centers will be screened until the target sample size of 110 HPV-positive women (55 from rural sites and 55 from urban sites) is reached. Cervical and vaginal swabs will be collected from all screened participants. For HPV-positive patients, HPV genotypes will be determined. One hundred ten healthy controls will be selected from previously screened volunteers. The cases and controls will comprise the multi-omics subset of participants and will be followed up after 6 and 12 months for repeat HPV screening. Metagenomic and metabolomic analyses of the vaginal swabs will also be performed at baseline, after 6 months, and after 12 months. The results of this study will update the prevalence and genotypic distribution of cervical HPV infection among Filipino women, determine whether the current vaccines used for HPV vaccination programs capture the most prevalent high-risk HPV genotypes in the country, and identify vaginal community state types and bacterial taxa associated with the natural history of cervical HPV infection. The results of this study will be used as the basis for developing a biomarker that can help predict the risk of developing persistent cervical HPV infection in Filipino women.

27 September 2022 in Cancer Epidemiology
Verified
Journal Article
Open access
CVClarissa L. Velayo
Clarissa L. Velayo
KRKareen N. Reforma
Kareen N. Reforma
RSRenee Vina G. Sicam
Renee Vina G. Sicam
MDMichele H. Diwa
Michele H. Diwa
ASAlvin Duke R. Sy
Alvin Duke R. Sy
OTOurlad Alzeus G. Tantengco
Ourlad Alzeus G. Tantengco
To evaluate the clinical performance and overall utility of imaging and biomarker assays in discriminating between benign and malignant ovarian masses in a Filipino population. This is a prospective cohort study among Filipino women undergoing assessment for an ovarian mass in a tertiary center. All included patients underwent a physical examination before level III specialist ultrasonographic and Doppler evaluation, multivariate index assay (MIA2G), and surgery for an adnexal mass. Ovarian tumors were classified as high-risk for malignancy based on the International Ovarian Tumour Analysis (IOTA) - Logistic Regression 2 (LR2) score. The ovarian imaging and biomarker results were correlated with the reference standard: histological findings. Among the 379 women with adnexal masses enrolled in this study, 291 were evaluable with ultrasound imaging, biomarker assays, and histopathological results. The risk of malignancy was higher for women classified as high-risk based on IOTA-LR2 (≥10%). The sensitivity, specificity, and diagnostic accuracy for the prediction of malignancy were 81.2%, 81%, and 0.81 (95% CI: 0.77-0.86) for IOTA-LR2; 77.5%, 66.7%, and 0.72 (95% CI: 0.67-0.77) for CA-125; and 91.3%, 41.2%, and 0.66 (95% CI: 0.62-0.71) for MIA2G. A combination of IOTA-LR2 and MIA2G significantly influenced the diagnostic performance and the result. When MIA2G was combined with IOTA-LR2 in parallel, the sensitivity (94.2%) and NPV (87.7%) increased, but the specificity (37.3%) decreased. When combined with IOTA-LR2 in series, there were fewer false positives, which resulted in improved specificity (85%). This study determined the utility of ovarian imaging and a second-generation multivariate index assay in predicting the risk of ovarian malignancy. IOTA-LR2 and MIA2G were useful in classifying patients with a high risk for ovarian malignancy.